Ceramide metabolism determines glioma cell resistance to chemotherapy

Journal of Cellular Physiology

Volumn 221, Issue 3, 2009, Pages 688-695

  Dumitru, Claudia Alexandra ^a   Weller, Michael ^b   Gulbins, Erich ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; GEMCITABINE; GLUCOSYLTRANSFERASE; SPHINGOMYELIN PHOSPHODIESTERASE; 1 PHENYL 2 PALMITOYLAMINO 3 MORPHOLINO 1 PROPANOL; 1-PHENYL-2-PALMITOYLAMINO-3-MORPHOLINO-1-PROPANOL; BAX PROTEIN, MOUSE; DEOXYCYTIDINE; DRUG DERIVATIVE; ENZYME INHIBITOR; GLUCOSYLCERAMIDE; MORPHOLINE DERIVATIVE; PROTEIN BAX; SMALL INTERFERING RNA; SPHINGOLIPID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL DEATH; CELL POPULATION; CELL STIMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG SENSITIVITY; ENZYME INHIBITION; ENZYME RELEASE; GLIOMA CELL; LIPID METABOLISM; LIPID STORAGE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; DRUG SCREENING; GENETICS; GLIOMA; METABOLISM; MITOCHONDRION; MOUSE; MOUSE STRAIN; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; CERAMIDES; DEOXYCYTIDINE; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; GLIOMA; GLUCOSYLCERAMIDES; GLUCOSYLTRANSFERASES; MICE; MICE, INBRED STRAINS; MITOCHONDRIA; MORPHOLINES; RNA, SMALL INTERFERING; SPHINGOLIPIDS; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR STEM CELL ASSAY;

EID: 70449726626     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21907     Document Type: Article

References (55)

1. Abe A, Inokuchi J, Jimbo M, Shimeno H, Nagamatsu A, Shayman JA, ShuklaGS, Radin NS. 1992. Improved inhibitors of glucosylceramide synthase. J Biochem 111:191-196.
2. Aronica E, Gorter JA, Redeker S, van Vliet EA, Ramkema M, Scheffer GL, Scheper RJ, van der Valk P, Leenstra S, Baayen JC, Spliet WG, Troost D. 2005. Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain. Epilepsia 46:849-857.
3. Bähr O, Rieger J, Duffner F, Meyermann R, Weller M, Wick W. 2003. P-glycoprotein and multidrug resistance-associated protein mediate specific patterns of multidrug resistance in malignant glioma cell lines, but not in primary glioma cells. Brain Pathol 13:482-494. (Pubitemid 37420693)
4. Becker I, Becker KF, Meyermann R, Höllt V. 1991. The multidrug-resistance gene MDR1 is expressed in human glial tumors. Acta Neuropathol 82:516-519.
5. Carpinteiro A, Dumitru C, Schenck M, Gulbins E. 2008. Ceramide-induced cell death in malignant cells. Cancer Lett 264:1-10.
6. Chen Z, Naito M, Hori S, Mashima T, Yamori T, Tsuruo T. 1999. A human IAP-family gene, apollon, expressed in human brain cancer cells. Biochem Biophys Res Commun 264:847-854.
7. Cremesti A, Paris F, Grassmé H, Holler N, Tschopp J, Fuks Z, Gulbins E, Kolesnick R. 2001. Ceramide enables fas to cap and kill. J Biol Chem 276:23954-23961. (Pubitemid 37410795)
8. Dobrowsky RT, Kamibayashi C, Mumby MC, Hannun YA. 1993. Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem 268:15523-15530.
9. Doyle LA, Ross DD. 2003. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22:7340-7358. (Pubitemid 37487163)
10. Dumitru CA, Gulbins E. 2006. TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis. Oncogene 25:5612-5625. (Pubitemid 44387617)
11. Esen M, Schreiner B, Jendrossek V, Lang F, Fassbender K, Grassmé H, Gulbins E. 2001. Mechanisms of Staphylococcus aureus induced apoptosis of human endothelial cells. Apoptosis 6:431-439. (Pubitemid 33078753)
12. Fleming TP, Saxena A, Clark WC, Robertson JT, Oldfield EH, Aaronson SA, Ali IU. 1992. Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res 52:4550-4553.
13. Fulda S, Debatin KM. 2006. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25:4798-4811. (Pubitemid 44187627)
14. Garcia-BarrosM, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z, Kolesnick R. 2003. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300:1155-1159. (Pubitemid 36583102)
15. Grammatikos G, Teichgraber V, Carpinteiro A, Trarbach T, WellerM, Hengge UR, Gulbins E. 2007. Overexpression of acid sphingomyelinase sensitizes glioma cells to chemotherapy. Antioxid Redox Signal 9:1449-1456. (Pubitemid 47255025)
16. Grassmé H, Gulbins E, Brenner B, Ferlinz K, Sandhoff K, Harzer K, Lang F, Meyer TF. 1997. Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells. Cell 91:605-615. (Pubitemid 27513652)
17. Grassmé H, Jekle A, Riehle A, Schwarz H, Berger J, Sandhoff K, Kolesnick R, Gulbins E. 2001a. CD95 signaling via ceramide-rich membrane rafts. J Biol Chem 276:20589-20596.
18. Grassmé H, Schwarz H, Gulbins E. 2001b. Molecular mechanisms of ceramide-mediated CD95 clustering. Biochem Biophys Res Commun 284:1016-1030. (Pubitemid 32924751)
19. Grassmé H, Cremesti A, Kolesnick R, Gulbins E. 2003a. Ceramide-mediated clustering is required for CD95-DISC formation. Oncogene 22:5457-5470. (Pubitemid 37072201)
20. Grassmé H, Jendrossek V, Riehle A, von Kurthy G, Berger J, Schwarz H, WellerM, Kolesnick R, Gulbins E. 2003b. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med 9:322-330. (Pubitemid 36362788)
21. Green DR. 2005. Apoptotic pathways: Ten minutes to dead. Cell 121:671-674.
22. Gulbins E, Kolesnick R. 2000. Measurement of sphingomyelinase activity. Methods Enzymol 322:382-388.
23. Haga S, Hinoshita E, Ikezaki K, Fukui M, Scheffer GL, Uchiumi T, Kuwano M. 2001. Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma. Jpn J Cancer Res 92:211-219. (Pubitemid 32237098)
24. Hannun YA, Obeid LM. 2008. Principles of bioactive lipid signalling: Lessons from sphingolipids. Nat Rev Mol Cell Biol 9:139-150.
25. Heinrich M, Wickel M, Schneider-BrachertW, Sandberg C, Gahr J, Schwandner R, Weber T, Saftig P, Peters C, Brunner J, Kronke M, Schutze S. 1999. Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J 18:5252-5263. (Pubitemid 29465576)
26. Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B, Nister M. 1992. Platelet-derived growth factor and its receptors in human glioma tissue: Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52:3213-3219.
27. Huwiler A, Johansen B, Skarstad A, Pfeilschifter J. 2001. Ceramide binds to the CaLB domain of cytosolic phospholipase A2 and facilitates its membrane docking and arachidonic acid release. FASEB J 15:7-9.
28. Ikediobi ON, Davies H, Bignell G, Edkins S, Stevens C, O'Meara S, Santarius T, Avis T, Barthorpe S, Brackenbury L, Buck G, Butler A, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Hunter C, Jenkinson A, Jones D, Kosmidou V, Lugg R, Menzies A, Mironenko T, Parker A, Perry J, Raine K, Richardson D, Shepherd R, Small A, Smith R, Solomon H, Stephens P, Teague J, Tofts C, Varian J, Webb T, West S, Widaa S, Yates A, ReinholdW, Weinstein JN, Stratton MR, Futreal PA, Wooster R. 2006. Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. Mol Cancer Ther 5:2606-2612.
29. Jan JT, Chatterjee S, Griffin DE. 2000. Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J Virol 74: 6425-6432. (Pubitemid 30429809)
30. Kolesnick RN, Goñi FM, Alonso A. 2000. Compartmentalization of ceramide signaling: Physical foundations and biological effects. J Cell Physiol 184:285-300. (Pubitemid 30625491)
31. Lacour S, Hammann A, Grazide S, Lagadic-Gossmann D, Athias A, Sergent O, Laurent G, Gambert P, Solary E, Dimanche-Boitrel MT. 2004. Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells. Cancer Res 64:3593-3598.
32. Lalier L, Cartron PF, Juin P, Nedelkina S, Manon S, Bechinger B, Vallette FM. 2007. Bax activation and mitochondrial insertion during apoptosis. Apoptosis 12:887-896. (Pubitemid 46653297)
33. Lavrik I, Golks A, Krammer PH. 2005. Death receptor signaling. J Cell Sci 118:265-267.
34. Liscovitch M, Ravid D. 2007.Acase study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8human ovarian carcinoma cells. Cancer Lett 245:350-352.
35. Liu YY, Han TY, Giuliano AE, Hansen N, Cabot MC. 2000. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. J Biol Chem 275:7138-7143. (Pubitemid 30146262)
36. Mahdy AE, Cheng JC, Li J, Elojeimy S,Meacham WD, Turner LS, Bai A, Gault CR, McPherson AS, Garcia N, Beckham TH, Saad A, Bielawska A, Bielawski J, Hannun YA, Keane TE, Taha MI, Hammouda HM, Norris JS, Liu X. 2008. Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer. Mol Ther 17:430-438.
37. McKenzie S, Kyprianou N. 2006. Apoptosis evasion: The role of survival pathways in prostate cancer progression and therapeutic resistance. J Cell Biochem 97:18-32. (Pubitemid 43050177)
38. Morita Y, Perez GI, Paris F, Miranda SR, Ehleiter D, Haimovitz-Friedman A, Fuks Z, Xie Z, Reed JC, Schuchman EH, Kolesnick RN, Tilly JL. 2000. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med 6:1109-1114. (Pubitemid 30792189)
39. Nurminen TA, Holopainen JM, Zhao H, Kinnunen PK. 2002. Observation of topical catalysis by sphingomyelinase coupled to microspheres. J Am Chem Soc 124:12129-12134. (Pubitemid 35154879)
40. Paris F, Fuks Z, Kang A, Capodieci P, Juan G, Ehleiter D, Haimovitz-Friedman A, Cordon-Cardo C, Kolesnick R. 2001. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293:293-297. (Pubitemid 32694744)
41. Pena LA, Fuks Z, Kolesnick RN. 2000. Radiation-induced apoptosis of endothelial cells in the murine central nervous system: Protection by fibroblast growth factor and sphingomyelinase deficiency. Cancer Res 60:321-327. (Pubitemid 30070758)
42. Reynolds CP, Maurer BJ, Kolesnick RN. 2004. Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett 206:169-180. (Pubitemid 38317287)
43. Ruvolo PP. 2001. Ceramide regulates cellular homeostasis via diverse stress signaling pathways. Leukemia 15:1153-1160.
44. Ruvolo PP, Deng X, Ito T, Carr BK, MayWS. 1999. Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. J Biol Chem 274:20296-20300.
45. Saad AF, Meacham WD,Bai A, Anelli V, Elojeimy S, Mahdy AE, Turner LS, Cheng BielawskaA, Bielawski J, Keane TE, Obeid LM, Hannun YA, Norris JS, Liu X. 2007. The functional effects of acid ceramidase overexpression in prostate cancer progression and resistance to chemotherapy. Cancer Biol Ther 6:1455-1460. (Pubitemid 351590358)
46. Salinas M, Lopez-Valdaliso R, Martin D, Alvarez A, Cuadrado A. 2000. Inhibition of PKB/Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells. Mol Cell Neurosci 15:156-169. (Pubitemid 30109119)
47. Santana P, Pena LA, Haimovitz-Friedman A, Martin S, Green D, McLoughlin M, Cordon-Cardo C, Schuchman EH, Fuks Z, Kolesnick R. 1996. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86:189-199. (Pubitemid 26286102)
48. Serano RD, Pegram CN, Bigner DD. 1980. Tumorigenic cell culture lines from a spontaneous VM/Dk murine astrocytoma (SMA). Acta Neuropathol 51:53-64.
49. Stegh AH, Kim H, Bachoo RM, Forloney KL, Zhang J, Schulze H, Park K, Hannon GJ, Yuan J, Louis DN, DePinho RA, Chin L. 2007. Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma. Genes Dev 21:98-111. (Pubitemid 46089711)
50. Steinbach JP,Weller M. 2004. Apoptosis in gliomas: Molecular mechanisms and therapeutic implications. J Neurooncol 70:245-254. (Pubitemid 39545735)
51. Wagenknecht B, Glaser T, Naumann U, Kugler S, Isenmann S, Bahr M, Korneluk R, Liston P, Weller M. 1999. Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma. Cell Death Differ 6:370-376. (Pubitemid 29186881)
52. Watson MB, Lind MJ, Cawkwell L. 2007. Establishment of in-vitro models of chemotherapy resistance. Anticancer Drugs 18:749-754.
53. Zeidan YH, Jenkins RW, Korman JB, LiuX, Obeid LM, Norris JS, Hannun YA. 2008. Molecular targeting of acid ceramidase: Implications to cancer therapy. Curr Drug Targets 9:653-661.
54. Zhang Y, Yao B, Delikat S, Bayoumy S, Lin XH, Basu S, McGinley M, Chan-Hui PY, Lichenstein H, Kolesnick R. 1997. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 89:63-72. (Pubitemid 27180586)
55. Ziegler DS, Kung AL, Kieran MW. 2008. Anti-apoptosis mechanisms in malignant gliomas. J Clin Oncol 26:493-500.